Bristol Myers Wins Dismissal of $6.4 Billion Lawsuit Over Celgene Drug Approval Delays
On Monday, Bristol Myers Squibb (NYSE: BMY) won the dismissal of a $6.4 billion lawsuit claiming it cheated former Celgene […]
Bristol Myers Wins Dismissal of $6.4 Billion Lawsuit Over Celgene Drug Approval Delays Read More »
